-27.5% -24.5% 2,120.4 1,782.4 -15.9% Other income 31.8 15.9 22.9 -28.1% +44.1% 51.7 38.7 -25.1% Selling and distribution expenses 587.2 536.7 463.7 -21.0% -13.6% 1,175.1 1,000.4 -14.9% Administrative
) % Revenue from sales and service 1,788.5 2,025.3 1,187.1 (236.8) (11.7) 601.4 50.7 Cost of sales and service 1,499.5 1,686.8 998.7 (187.3) (11.1) 500.8 50.1 Selling and distribution expenses 73.7 78.7 52.0
sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the
0.00 12.21 N/A 6.95% 0.00% Revenues from reduction of defaulted interest under the Court’s order 16.66 0.00 16.66 N/A 9.48% 0.00% Distribution costs (24.14 ) (26.13 ) (1.99 ) 7.62% (13.74%) (8.83
smart solutions to improve the efficiency and productivity of their businesses. Nonetheless, economic concerns also persisted in this customer segment, especially in small and medium enterprises, and
trustee, under Clause 20; (13) the trust’s disclosure of information, under Clause 21; (14) the distribution to the unit holders, under Clause 22; (15) the proposal for resolution and the general meeting of
improvements in productivity, we achieved a gross profit of 281.47mb (2018: 237.71mb), an increase of 43.76mb or 18.4%. Selling and Administration expense Selling and administration expense ( “ SG&A” ) closed at
, respectively, decreased by Baht 151.02 million or 9.17 %. This is mainly because of our continuous improvement since 2019 on our productivity, cost - 3 - reduction, Kaizen and 4DX Cost saving activities
overall improvements in productivity, we achieved a gross profit of 202.75mb ( Q3 2018: 163.17mb), an increase of 39.58mb or 24.3%. Selling and Administration expense Selling and administration expense (“SG